OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Tuberculosis and Lung Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Dr Christopher Zishiri	184
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	130
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	61
TB-related deaths among adults in Guinea-Bissau	55
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	49
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	43
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	36
TB in ageing populations: lessons from Japan and Korea	35
The impact of sputum quality on Xpert positivity in active case-finding for TB	32
New approaches to improve communication and adherence to treatment of TB infection in migrants	30
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	23
CFU counting may underestimate TB bacilli number of blood, biasing limit of detection estimates in spiking experiments	22
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	20
TB infection in adults with diabetes mellitus in Uganda	20
Yield of community outreach events for TB screening	19
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	18
Launch of a second wave of IJTLD Clinical Standards for Lung Health	17
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	17
Screening of refugees from Ukraine for TB: a TBnet survey	17
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	17
Standards for clinical trials for treating TB	16
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	16
Latent TB and depressive symptoms in household contacts of persons with active TB	16
The COVID-19 pandemic does not bode well for TB control	16
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	16

Occupational transmission of TB infection during autopsy	16
Are schools prepared to manage students with an asthma attack?	15
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	15
Assessment of TB patient cost – what about the mitigation strategy?	14
Performance of spirometry assessment at TB diagnosis	14
Perceived stigma among people with TB and household contacts	14
Literature Highlights	14
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	14
Mycobacteria susceptibility to epetraborole: how far can it go?	13
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	13
Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers	13
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	13
Accessibility and TB patient satisfaction in Nigeria	12
Patterns of TB transmission in the United States, 2011–2017	11
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	11
A novel method for contact tracing for TB at household and community level	11
Paediatric TB care in the United Kingdom	11
A cohort study exploring variables associated with mortality in critically ill TB patients	11
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	11
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	11
Facilitators and barriers to adolescent participation in a TB clinical trial	10
How incarceration can amplify TB: a preventable public health failure in Ecuador	10
Decentralising TB diagnosis and contact management: impact on detection and preventive treatment in children	10
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	10
TB disease yield from household contact screening of TB index patients in Pakistan	10
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	10
Health status of Italian children living close to cultivations sprayed with pesticides	10
Population attributable fraction for smoking and diabetes in TB	10
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	10
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	9
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	9
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	9
Risk factors for severe COPD exacerbation in Chinese adults	9
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	9
The prevalence of post-TB bronchiectasis: lessons from the Spanish registeries	9
Post-TB lung disease: keep going beyond TB!	9
Cascade of care for people with TB and diabetes in India	9
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	8
Cost of TB prevention and treatment in the Philippines in 2017	8
Characteristics, risk factors and outcomes of critically ill patients with active TB	8
Community-based intervention and health education to scale up TB preventive treatment for children	8
Proportions of Xpert MTB/RIF Ultra ‘trace’ results vary widely among different populations with presumptive TB	8
Perceived stigma related to TB preventive therapy	8
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	8
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	8
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	8
Meeting of two pandemics in prison: a challenging event in a challenging environment	8
If you want to go far, go together: standardisation and data sharing in TB drug development	8
Use of computed tomography for the diagnosis of TB during a paediatric outbreak	8
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	8

TB notifications among citizens and non-citizens in Taiwan	8
Contribution of Xpert^® MTB/RIF to pediatric TB diagnosis in Mozambique	8
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	7
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	7
Estimating TB survival ‐ mind the immortal-time gap	7
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	7
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	7
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	7
The high costs facing TB-affected households in Mali	7
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	7
The diagnostic accuracy of interferon-gamma release assay for TB infection in children under 5 years: a systematic review with meta-analysis	7
Extemporaneously compounded liquid formulations of clofazimine	7
Effect of biological therapies on TB treatment outcomes	7
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	7
Non-TB mycobacterial diseases: negligence or helplessness?	7
A new understanding of clinical patterns in post-TB lung disease	7
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	7
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	7
Predictors of TB disease in HIV-exposed children from Southern Africa	7
Mycobacterium tuberculosis genotypes isolated from clinical specimens of extrapulmonary TB	7
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs	6
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	6
Implementation of modified, all-oral shorter TB regimens in Armenia	6
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	6
Family directly observed therapy for children with drug-resistant TB	6
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	6
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	6
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	6
TB mortality in low-incidence countries: can we reduce it further?	6
Diabetes characteristics and long-term management needs in diabetic TB patients	6
Early line-probe assay using DNA specimens in patients with pulmonary TB	6
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	6
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	6
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	6
WHO drug-resistant TB guidelines 2022: what is new?	6
TB screening of Ukrainian refugees in Germany	6
TB and COVID-19 co-infection in a pulmonology hospital	6
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	6
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	6
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	6
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	6
Factors associated with presenting to private sector care providers at the onset of TB symptoms	6
Literature Highlights	6
Glutathione and N-acetylcysteine in TB management	6
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	6
Bronchiectasis exacerbations: certainties and future challenges	6
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	5
Potential use of nasopharyngeal aspirate for pediatric TB diagnosis	5
Differentiated service delivery for TB treatment	5
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	5
Borderline T-SPOT.TB results: test reliability, patient characteristics, and TB progression	5
Undernutrition assessment and nutrient intake of people with TB in the Philippines	5
Factors associated with referrals for directly observed treatment and unsuccessful treatment	5
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	5
TB screening, prevention and treatment cascade in a Malawi prison	5
Establishing proof of concept for utility of Trueprep^®-extracted DNA in line-probe assay testing	5
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	5
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	5
Eosinophils in bronchiectasis: searching for a new endotype	5
Bridging the gap: key evidence needed to strengthen global policies to end TB	5
TB screening of children from Ukraine in Germany	5
Temporal trends in treatment strategies and outcomes of newly diagnosed Mycobacterium avium complex pulmonary disease	5
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	5
Evaluation of the MolecuTech^® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	5
Clinical outcomes in comorbid COVID-19 and TB cases	5
Bridging the gap in TB diagnostic strategies between technical sophistication and real-world applicability in low-resource settings	5
Reducing stigma among vulnerable populations with TB: insights from a community intervention	5
Cascade of TB care in Indigenous populations in South America: a scoping review	4
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	4
Respiratory health of conch shell workers: insights from West Bengal, India	4
Effect of HIV on bedaquiline and delamanid pharmacokinetics in patients with multidrug-resistant TB	4
Preventing household TB transmission with portable air cleaners and fans	4
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	4
Artificial intelligence for TB education and counselling: a modified Delphi consensus	4
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	4
Therapeutic drug monitoring for isoniazid and rifampicin exposure	4
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	4
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	4
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	4
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	4

National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	4
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	4
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	4
Highlighting the characteristics of TB disease in older people	4
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	4
Post-TB bronchiectasis: clinical characteristics and microbiology	4
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	4
A comprehensive person-centred TB care model, from malnutrition to mental health	4
Programmatic implications of a sub-national TB prevalence survey in India	4
Preventing lung function decline and pleural thickening after pleural TB: a systematic review	4
Extra-pulmonary TB: a comparison between migrants and populations born in a low-incidence country	4
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	4
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	4
An adapted scale to measure perceived TB and HIV stigma during household contact investigation	3
Clinical standards for drug-susceptible TB in children and adolescents	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Factors influencing treatment outcomes in patients with isoniazid-resistant pulmonary TB	3
The interplay between TB and lung cancer: risk, prognosis and treatment dynamics	3
Post-TB lung disease – the rationale for a Clinical Statement	3
Ocular TB in Western Australia	3
BMI as a predictor of progression from TB infection to active TB in PLHIV	3
The effect of TB patient delay on loss to follow-up in Portugal	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
Increasing trend of non-tuberculous mycobacteria in a Croatian hospital, 2012–2019	3
A comparison of bronchoalveolar lavage and gastric aspirate for diagnosis of paediatric TB	3
Obituary for Donald A. Enarson	3
Characterising cause of death among people treated for drug-susceptible TB in India	3
Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA	3
Assessing air pollution exposure in children at school: toward a source-specific exposure matrix	3
Impact of indoor ventilation on TB transmission risk: implications of climate change	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
The effect of medication event reminder monitoring on treatment adherence of TB patients	3
Expanding the diagnosis of TB and nontuberculous infections using real-time PCR in fixed tissue	3
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids	3
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose	3
Prevalence, temporal trends and risk factors of drug-resistant TB in Zibo, China, 2018–2021	3
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
Contributions of GeneXpert^® to TB diagnosis in Myanmar	3
Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment	3
Preventive treatment for MDR-TB exposure in households	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
Anatomical and functional characteristics of symptomatic post-TB lung disease	3
Spatiotemporal and risk factor analysis of drug-sensitive and drug-resistant TB in West Java, 2020–2022	3
A structured 2-week follow-up visit in the cascade of care for TB increases case detection	3
Understanding systematic rifampicin resistance errors with the FluoroType MTBDR VER 2.0	3
Male reproductive hormones in patients treated with pretomanid	3
Effect of community awareness, screening, testing, and treatment campaigns on TB prevention	3
Association between chronic obstructive pulmonary disease and biomass smoke in rural areas	3
Towards meaningful inclusion of people affected by TB: lessons from the COVID-19 response	3
Clinical standards for the dosing and management of TB drugs	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
Risk of hospitalised bronchiectasis exacerbation based on blood eosinophil counts	3
TB in the elderly: clinical features and outcomes	3
Comparing the MiniBox™ and the Chestac-8900^® for pulmonary function testing	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
The economic burden of TB faced by patients and affected families in Papua New Guinea	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
Work-related interstitial lung diseases: reassessing the burden	3
Outcomes for people with TB by disease severity at presentation	3
Factors associated with pulmonary TB in malnourished children admitted to rehabilitation centres	3
Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda	3
Lung function and health-related quality of life among adult patients following pulmonary TB treatment	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Ukraine embraces innovation in its fight against another deadly foe: TB	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
Adverse events among persons with TB using in-person vs. electronic directly observed therapy	3
TAPSE/sPAP ratio can be used to predict pulmonary hypertension in fibrosing interstitial lung disease	2
Combating the tridemic: new guidelines, masking and altruism	2
Does childhood TB or pneumonia impact COPD or asthma in adulthood?	2
Successes and challenges of latent TB screening and treatment in a high-prevalence US region	2
Omadacycline enhances the in vitro activity of clofazimine against Mycobacterium abscessus	2
Tobacco cessation services in the Indian state of Uttarakhand	2
Literature Highlights	2
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB	2
An update on the IJTLD: our latest impact factor and influence on policy-making	2
Creative approaches to monitoring and evaluating community-based treatment programmes for TB infection	2
Use of a mobile sensor to measure PM_2.5 and its fluctuations with weather conditions in Bangkok	2
Tackling TB in Europe: treatment gaps and deteriorating treatment availability is undermining progress	2
Asthma and allergies in schoolchildren: data from the European SINPHONIE study	2
Reasons for acceptance or nonparticipation in iAdhere: a trial of latent TB infection treatment	2
A non-invasive, sensitive assay for active TB: combined cell-free DNA detection and FluoroSpot assays	2
Evaluating the impact of COVID-19 or SARS-CoV-2 vaccination on TB infection testing in the context of TB elimination	2
Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs	2
Lower FEV ₁ and gram-negative bacilli isolation as independent risk factors for exacerbations in post-TB bronchiectasis	2
Zooanthroponosis and zoonotic TB: a call for a One Health approach	2
Monitoring TB infection in contact cases: the impact of the COVID-19 pandemic	2
Randomized, controlled trial of a protein-calorie supplement for women coinfected with HIV-TB	2
Cross-sectional versus longitudinal estimates of annual risk of TB infection	2
Implementing TB preventive therapy: lessons from a large-scale initiative in India	2
Co-administration of treatment for drug-resistant TB and hepatitis C	2
Further effort is needed to avoid irrational use after drug susceptibility testing for drug-resistant TB	2
Dynamics of Xpert MTB/RIF Ultra results in follow-up sputum samples during the first month of TB treatment	2
Clinical outcomes of linezolid-related adverse events in patients with multidrug-resistant TB	2
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children	2
Monocyte-lymphocyte ratio – diagnostic cut-off values and TB infection or disease	2